Iterum Therapeutics (ITRM) Expected to Announce Earnings on Friday

Iterum Therapeutics (NASDAQ:ITRM) is expected to be posting its quarterly earnings results before the market opens on Friday, February 7th. Analysts expect Iterum Therapeutics to post earnings of ($0.26) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Iterum Therapeutics Stock Performance

Iterum Therapeutics stock opened at $1.55 on Wednesday. Iterum Therapeutics has a fifty-two week low of $0.81 and a fifty-two week high of $3.02. The stock has a market cap of $42.66 million, a P/E ratio of -0.78 and a beta of 2.28. The firm’s fifty day moving average price is $1.84 and its 200-day moving average price is $1.43.

About Iterum Therapeutics

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections.